
In time for the upcoming 2006-07 flu season, a new influenza immunization is available from GlaxoSmithKline. FluLaval (Influenza Virus Vaccine) has been approved for the active immunization of adults 18 years of age and older against influenza types A and B. FluLaval, already marketed in Canada under the name Fluviral, will be available in 10-dose multi-dose vials.